0001104659-15-065569.txt : 20150916
0001104659-15-065569.hdr.sgml : 20150916
20150916170239
ACCESSION NUMBER: 0001104659-15-065569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150915
FILED AS OF DATE: 20150916
DATE AS OF CHANGE: 20150916
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SYDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SYDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Ravindra
CENTRAL INDEX KEY: 0001586835
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 151110762
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2015-09-15
0
0001280600
ACCELERON PHARMA INC
XLRN
0001586835
Kumar Ravindra
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
VP & Chief Scientific Officer
Common Stock
2015-09-15
4
M
0
11485
3.88
A
89685
D
Common Stock
2015-09-15
4
S
0
33000
35
D
56685
D
Option to Purchase Common Stock
3.88
2015-09-15
4
M
0
11485
0
D
2020-12-02
Common Stock
11485
13515
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.
/s/ John D. Quisel, as attorney-in-fact for Ravindra Kumar
2015-09-16